Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov 6;12(11):3282.
doi: 10.3390/cancers12113282.

Thyroid Lobectomy for Low to Intermediate Risk Differentiated Thyroid Cancer

Dana M Hartl  1 , Joanne Guerlain  1 , Ingrid Breuskin  1 , Julien Hadoux  2 , Eric Baudin  2 , Abir Al Ghuzlan  3 , Marie Terroir-Cassou-Mounat  2 , Livia Lamartina  2 , Sophie Leboulleux  2
Affiliations
Review

Thyroid Lobectomy for Low to Intermediate Risk Differentiated Thyroid Cancer

Dana M Hartl et al. Cancers (Basel). .

Abstract

Many recent publications and guidelines have promoted a "more is less" approach in terms of treatment for low to intermediate risk differentiated thyroid cancer (DTC), which comprise the vast majority of thyroid cancers: less extensive surgery, less radioactive iodine, less or no thyroid hormone suppression, and less frequent or stringent follow-up. Following this approach, thyroid lobectomy has been proposed as a means of decreasing short- and long-term postoperative morbidity while maintaining an excellent prognosis for tumors meeting specific macroscopic and microscopic criteria. This article will examine the pros and cons of thyroid lobectomy for low to intermediate risk cancers and discuss, in detail, criteria for patient selection and oncological outcomes.

Keywords: lobectomy; prognosis; risk stratification; thyroid cancer; thyroidectomy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Haugen B.R., Alexander E.K., Bible K.C., Doherty G.M., Mandel S.J., Nikiforov Y.E., Pacini F., Randolph G.W., Sawka A.M., Schlumberger M., et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26:372–381. doi: 10.1089/thy.2015.0020. - DOI - PMC - PubMed
    1. Hartl D., Hadoux J., Guerlain J., Breuskin I., Haroun F., Bidault S., Leboulleux S., Lamartina L. Risk-oriented concept of treatment for intrathyroid papillary thyroid cancer. Best Pr. Res. Clin. Endocrinol. Metab. 2019;33:101281. doi: 10.1016/j.beem.2019.05.005. - DOI - PubMed
    1. Mathonnet M., Cuerq A., Tresallet C., Thalabard J.-C., Fery-Lemonnier E., Russ G., Leenhardt L., Bigorgne C., Tuppin P., Millat B., et al. What is the care pathway of patients who undergo thyroid surgery in France and its potential pitfalls? A national cohort. BMJ Open. 2017;7:013589. doi: 10.1136/bmjopen-2016-013589. - DOI - PMC - PubMed
    1. Meltzer C., Irish J., Angelos P., Busaidy N.L., Davies L., Dwojak S., Ferris R.L., Haugen B.R., Harrell R.M., Haymart M.R., et al. American Head and Neck Society Endocrine Section clinical consensus statement: North American quality statements and evidence-based multidisciplinary workflow algorithms for the evaluation and management of thyroid nodules. Head Neck. 2018;41:843–856. doi: 10.1002/hed.25526. - DOI - PubMed
    1. Zolin S.J., Burneikis T., Rudin A.V., Shirley R.B., Siperstein A. Analysis of a thyroid nodule care pathway: Opportunity to improve compliance and value of care. Surgery. 2019;166:691–697. doi: 10.1016/j.surg.2019.05.054. - DOI - PubMed

LinkOut - more resources